COVID, Pneumonia, Viral
Conditions
Brief summary
Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .
Detailed description
Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .
Interventions
DEVICEBedside lung ultrasound
Point of care ultrasound will be used as bedside lung ultrasound to determine the patients if they have a COVID-19 pneumonia.
Sponsors
Kanuni Sultan Suleyman Training and Research Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All patients with an informed consent * Admission to emergency department with symptoms or signs of COVID-19
Exclusion criteria
* Absence of informed consent * Patients under age of 18 * Presence of acute coronary syndrome * Presence of chronic lung disease * Pregnancy * Presence of trauma * Patients with a diagnosis of malignancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Presence of viral pneumonia caused by COVID 19 | 3 months | Efficacy of POCUS on diagnosis of viral pneumonia caused by COVID 19 |
Countries
Turkey (Türkiye)
Contacts
Primary ContactRamazan Guven
Backup ContactSeda Yilmaz Semerci
Outcome results
None listed